1)Dosage Form Characteristics:
This lyophilized powder is intended for reconstitution and parenteral administration, providing rapid, stable systemic drug exposure. It is ideally suited for acute or critically ill patients.
2)Indications:
• Amyotrophic lateral sclerosis (ALS)
• Stroke (acute, subacute, and post-stroke rehabilitation phases)
• Neurodegenerative diseases such as Alzheimer’s disease (AD)
3)Key Advantages:
• Potent Systemic Effect: Intravenous or intramuscular injection allows for fast onset of action.
• Precise Dose Control: Facilitates accurate titration and adjustment of therapeutic dosing.